Raimondo, Paola, Market Access Analyst, Market Access Provider, Milano, Italy, Italy

• Vol 22, No 1 (2021) - Original research
  A Budget Impact Analysis of the VENTANA PD-L1 SP142 Immunohistochemistry Assay Versus the Dako PD-L1 IHC 22C3 Assay in Patients With Advanced or Metastatic Triple-Negative Breast Cancer Treated With Atezolizumab in Combination With Nab-Paclitaxel
  Abstract  HTML  PDF